Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912147740> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2912147740 abstract "337 Background: Diabetes mellitus (DM) and hyperglycemia have been widely considered to be associated with the risk of pancreatic cancer. However, the aim of this study was to evaluate the relationship between glycemic control and the efficacy or safety in pancreatic cancer pts receiving treatment with nab-Paclitaxel (nab-PTX) plus Gemcitabine (GEM). Methods: We retrospectively reviewed 285 pts with unresectable pancreatic cancer with nab-PTX plus GEM as the first-line chemotherapy from December 2014 to March 2017 at the National Cancer Center Hospital East, Kashiwa, Japan. The pts were divided into two groups, average blood glucose level during the period of chemotherapy was less than 160 mg/dL (Group GC: Good glycemic control group) and more than 160 mg/dL (Group PC: Poor glycemic control group). Results: A total of 285 pts were enrolled. Median age was 66 years (range: 26-84) and males/females: 180/105, PS (0-1/2-3): 272/13, stage (III/IV): 77/208. There were 226 pts in GC group and 59 pts in PC group. No significant differences were seen in the overall survival between Group GC and PC (median: 16.1 months vs. 13.8 months, p = 0.344) and in the progression free survival between the two groups (median: 7.5 months vs. 8.2 months, p = 0.862). The incidence rate of grade 2-3 chemotherapy-induced peripheral neuropathy (CIPN) was significantly higher in Group PC compared with Group GC (Group GC 28.3%, Group PC 45.8%, p = 0.010). Univariate and multivariate analyses identified glycemic control as significant independent factors associated with the incidence of grade 2-3 of CIPN (Odds ratio 2.182, 95% CI 1.20-3.96, p = 0.010). There was no significant difference in the relative dose intensity of nab-PTX between two groups (median, 56.6% in group GC, 56.5% in group PC, p = 0.952). Conclusions: Glycemic control during the chemotherapy with nab-PTX plus GEM in unresectable pancreatic cancer was not associated with OS. The incidence of severe CIPN was higher in pts with poor glycemic control compared with good glycemic control." @default.
- W2912147740 created "2019-02-21" @default.
- W2912147740 creator A5006683327 @default.
- W2912147740 creator A5018170175 @default.
- W2912147740 creator A5021407007 @default.
- W2912147740 creator A5022537134 @default.
- W2912147740 creator A5027837608 @default.
- W2912147740 creator A5033775542 @default.
- W2912147740 creator A5034116932 @default.
- W2912147740 creator A5040580329 @default.
- W2912147740 creator A5062757390 @default.
- W2912147740 creator A5064282637 @default.
- W2912147740 creator A5072969214 @default.
- W2912147740 creator A5076202712 @default.
- W2912147740 creator A5078772421 @default.
- W2912147740 creator A5079400443 @default.
- W2912147740 creator A5079504645 @default.
- W2912147740 date "2019-02-01" @default.
- W2912147740 modified "2023-10-16" @default.
- W2912147740 title "Impact of glycemic control on treatment efficacy and safety during nabpaclitaxel plus gemcitabine therapy in unresectable pancreatic cancer." @default.
- W2912147740 doi "https://doi.org/10.1200/jco.2019.37.4_suppl.337" @default.
- W2912147740 hasPublicationYear "2019" @default.
- W2912147740 type Work @default.
- W2912147740 sameAs 2912147740 @default.
- W2912147740 citedByCount "0" @default.
- W2912147740 crossrefType "journal-article" @default.
- W2912147740 hasAuthorship W2912147740A5006683327 @default.
- W2912147740 hasAuthorship W2912147740A5018170175 @default.
- W2912147740 hasAuthorship W2912147740A5021407007 @default.
- W2912147740 hasAuthorship W2912147740A5022537134 @default.
- W2912147740 hasAuthorship W2912147740A5027837608 @default.
- W2912147740 hasAuthorship W2912147740A5033775542 @default.
- W2912147740 hasAuthorship W2912147740A5034116932 @default.
- W2912147740 hasAuthorship W2912147740A5040580329 @default.
- W2912147740 hasAuthorship W2912147740A5062757390 @default.
- W2912147740 hasAuthorship W2912147740A5064282637 @default.
- W2912147740 hasAuthorship W2912147740A5072969214 @default.
- W2912147740 hasAuthorship W2912147740A5076202712 @default.
- W2912147740 hasAuthorship W2912147740A5078772421 @default.
- W2912147740 hasAuthorship W2912147740A5079400443 @default.
- W2912147740 hasAuthorship W2912147740A5079504645 @default.
- W2912147740 hasConcept C120665830 @default.
- W2912147740 hasConcept C121332964 @default.
- W2912147740 hasConcept C121608353 @default.
- W2912147740 hasConcept C126322002 @default.
- W2912147740 hasConcept C141071460 @default.
- W2912147740 hasConcept C144301174 @default.
- W2912147740 hasConcept C2776694085 @default.
- W2912147740 hasConcept C2779306644 @default.
- W2912147740 hasConcept C2780210213 @default.
- W2912147740 hasConcept C2780258809 @default.
- W2912147740 hasConcept C2780473172 @default.
- W2912147740 hasConcept C38180746 @default.
- W2912147740 hasConcept C61511704 @default.
- W2912147740 hasConcept C71924100 @default.
- W2912147740 hasConcept C90924648 @default.
- W2912147740 hasConceptScore W2912147740C120665830 @default.
- W2912147740 hasConceptScore W2912147740C121332964 @default.
- W2912147740 hasConceptScore W2912147740C121608353 @default.
- W2912147740 hasConceptScore W2912147740C126322002 @default.
- W2912147740 hasConceptScore W2912147740C141071460 @default.
- W2912147740 hasConceptScore W2912147740C144301174 @default.
- W2912147740 hasConceptScore W2912147740C2776694085 @default.
- W2912147740 hasConceptScore W2912147740C2779306644 @default.
- W2912147740 hasConceptScore W2912147740C2780210213 @default.
- W2912147740 hasConceptScore W2912147740C2780258809 @default.
- W2912147740 hasConceptScore W2912147740C2780473172 @default.
- W2912147740 hasConceptScore W2912147740C38180746 @default.
- W2912147740 hasConceptScore W2912147740C61511704 @default.
- W2912147740 hasConceptScore W2912147740C71924100 @default.
- W2912147740 hasConceptScore W2912147740C90924648 @default.
- W2912147740 hasLocation W29121477401 @default.
- W2912147740 hasOpenAccess W2912147740 @default.
- W2912147740 hasPrimaryLocation W29121477401 @default.
- W2912147740 hasRelatedWork W133898433 @default.
- W2912147740 hasRelatedWork W2000894976 @default.
- W2912147740 hasRelatedWork W2005537476 @default.
- W2912147740 hasRelatedWork W2059464886 @default.
- W2912147740 hasRelatedWork W2171607164 @default.
- W2912147740 hasRelatedWork W2291674451 @default.
- W2912147740 hasRelatedWork W2319496893 @default.
- W2912147740 hasRelatedWork W2376347278 @default.
- W2912147740 hasRelatedWork W2421782557 @default.
- W2912147740 hasRelatedWork W2777687606 @default.
- W2912147740 isParatext "false" @default.
- W2912147740 isRetracted "false" @default.
- W2912147740 magId "2912147740" @default.
- W2912147740 workType "article" @default.